drugset / Trial / NCT05184049
Effects of Epalrestat on Peripheral Neuropathy and Central Nervous System in Diabetic Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This study evaluated the efficacy of epalrestat in diabetic peripheral neuropathy and its effects on the central nervous system in diabetic peripheral neuropathy subjects.
Timeline
- Start
- 2022-01
- Primary completion
- 2023-10
- Completion
- 2023-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epalrestat | Small molecule | 50 mg | Oral |
| Background | methylcobalamin | Small molecule | 0.5 mg | Oral |